HOME >> MEDICINE >> NEWS
NIH convenes panel to assess evidence on chronic insomnia

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on the Manifestations and Management of Chronic Insomnia in Adults on June 13-15, 2005, at the Natcher Conference Center, on the NIH campus in Bethesda, MD. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, June 15.

During the first day and part of the second day of the conference, experts will present the latest findings in the research of chronic insomnia to an independent panel. The panel will then meet in executive session to weigh the available scientific evidence and prepare its statement assessing the state of the science, to be presented for public comment at 9:00 a.m. on Wednesday, June 15.

Insomnia is the most common sleep complaint reported by women and men across all stages of adulthood and for many, the problem is chronic. While insomnia often exists simultaneously with other medical conditions (co-morbidities), the definitive etiology (cause) of insomnia remains unknown. Nevertheless, chronic insomnia is associated with a wide range of adverse consequences (morbidities), including depression, alcohol and drug abuse, difficulties with concentration and memory, and various cardiovascular, pulmonary, and gastrointestinal disorders. In addition to reduced quality of life and increased health care use reported by insomnia sufferers, the large number of people experiencing insomnia ultimately results in significant economic burden to society in lost productivity and health care costs. Although a number of promising behavioral and pharmacological approaches have recently been identified for the management of chronic insomnia symptoms, there has been limited guidance for clinicians in terms of choice of treatment.

The panel's statement will address these five key questions:

  • How is chronic insomnia defined, diagnosed, and classified, and what is known about its etiology?
  • What are the prevalenc
    '"/>


Contact: OMAR Information Center
nihcdp@mail.nih.gov
888-644-2667
NIH/Office of the Director
3-Jun-2005


Page: 1 2 3

Related medicine news :

1. American College of Physicians Foundation convenes conference
2. New Orleans levee report finished by panel including University of Texas at Austin engineer
3. IOF and EU panel prepare osteoporosis audit
4. RAND panel identifies key components of public health emergency preparedness
5. Medical, IT, engineering experts form advisory panel for electronic health record safety
6. SCAI expert panel sets high standards for PCI without on-site cardiac surgical backup
7. Conference on health communication call for papers and panel proposals
8. Consensus panel calls for expanded role of needle biopsies, MRI and less invasive procedures
9. Independent panel to evaluate a chemical used in some plastics for hazards to human health
10. Children need 60 minutes of daily physical activity, expert panel says
11. Children need 60 minutes of daily physical activity, expert panel says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH convenes panel assess evidence chronic insomnia

(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... Santa Rosa, CA (PRWEB) March 05, 2015 ... Like a SuperPro! The series aims to teach viewers ... indoor garden with hydroponics. Grow Like a SuperPro takes you ... in between. From how to clone, to how to prune ... of growing. They are offering the whole series for download ...
(Date:3/5/2015)... March 05, 2015 Califia Farms ... announced at Natural Products Expo West that its popular ... 100 percent soy and dairy free. Califia Farms Vegan ... bottle and are packed with six grams of an ... includes fiber, B vitamins and magnesium. , Protein is ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... the purest and most essential ingredients, the robust flavor ... of allergic reactions. PASCHA Chocolate is free from ... and sesame. Experience PASCHA's offering March 6th- 8th at ... Chocolate Spread. PASCHA Chocolate has broken new ground ...
(Date:3/5/2015)... 05, 2015 Today, Earth Source ... on 100% pollution-free electricity through a partnership with ... As an Arcadia Power Clean Energy Partner, ESO ... Power Partnership requirements, joining national brands such as ... clean energy. Earth Source Organics joins a growing ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, announced today that Atlanta ... rehabilitation hospitals for spinal cord injury and brain injury, ... of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients ... (SCI). The Phase 1/2a trial follows ...
(Date:3/5/2015)... March 5, 2015  MGC Diagnostics Corporation (NASDAQ: ... company, today reported financial results for the first ... 2015 first quarter domestic equipment, supplies and accessories ... $3.7 million in the 2014 first quarter.  During ... or $338,000 in revenue, compared to 14 accounts, ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
Cached News: